Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure
Autor: | Norihiko Takeda, Kenji Takemoto, Saori Ohmae, Satoru Seo, Shinji Uemoto, Masataka Asagiri, Hirokazu Tanaka, Naruto Noma, Shigehira Saji, Keigo Machida, Kazutaka Tanabe, Masatoshi Takeiri, Kojiro Taura, Etsuro Hatano, Keiko Iwaisako, Kan Toriguchi |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2014 |
Předmět: |
Necrosis
AST aspartate aminotransferase Pharmacology DMSO dimethyl sulfoxide medicine.disease_cause Fulminant hepatic failure bFGF basic fibroblast growth factor NAPQI N-acetyl-p-benzoquinone CXCL1 chemokine (C-X-C motif) ligand 1 GSH glutathione lcsh:QH301-705.5 chemistry.chemical_classification LDH lactate dehydrogenase digestive oral and skin physiology CM-H2DCFDA 5-(and-6)-chloromethyl-2′ 7′-dichlorodihydrofluorescein diacetate acetyl ester CYP2E1 cytochrome P450 2E1 WST-8 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2 4-disulfophenyl)-2H-tetrazolium Necroptosis medicine.symptom λPP lambda protein phosphatase medicine.drug Programmed cell death SNAP S-nitroso-N-acetyl-dl-penicillamine APAP acetaminophen General Biochemistry Genetics and Molecular Biology Article PI propidium iodide RIPK1 ROS reactive oxygen species FBS fetal bovine serum ABTS 2 2′-azino-bis (3-ethylbenzothiazoline)-6-sulfonic acid ALF acute liver failure PGAM5 phosphoglycerate mutase family member 5 ALT alanine aminotransferase medicine RIPK receptor-interacting protein kinase Drp1 dynamin-related protein 1 ComputingMethodologies_COMPUTERGRAPHICS Acetaminophen Reactive oxygen species NO nitric oxide RIPK-dependent necrosis Nec-1 necrostatin-1 lcsh:Biology (General) chemistry Immunology Hepatocytes Oxidative stress Acute liver failure |
Zdroj: | FEBS Open Bio FEBS Open Bio, Vol 4, Iss C, Pp 777-787 (2014) |
ISSN: | 2211-5463 |
Popis: | Graphical abstract Highlights • RIPK-dependent necrosis is involved in acetaminophen (APAP)-induced hepatotoxicity. • Necrostatin-1 (Nec-1) protects mice against APAP-induced acute liver damage. • Nec-1 suppresses APAP-induced ROS generation in hepatocytes. • Nec-1 promotes resistance to oxidative stress in hepatocytes. Excessive acetaminophen (APAP) use is one of the most common causes of acute liver failure. Various types of cell death in the damaged liver are linked to APAP-induced hepatotoxicity, and, of these, necrotic cell death of hepatocytes has been shown to be involved in disease pathogenesis. Until recently, necrosis was commonly considered to be a random and unregulated form of cell death; however, recent studies have identified a previously unknown form of programmed necrosis called receptor-interacting protein kinase (RIPK)-dependent necrosis (or necroptosis), which is controlled by the kinases RIPK1 and RIPK3. Although RIPK-dependent necrosis has been implicated in a variety of disease states, including atherosclerosis, myocardial organ damage, stroke, ischemia–reperfusion injury, pancreatitis, and inflammatory bowel disease. However its involvement in APAP-induced hepatocyte necrosis remains elusive. Here, we showed that RIPK1 phosphorylation, which is a hallmark of RIPK-dependent necrosis, was induced by APAP, and the expression pattern of RIPK1 and RIPK3 in the liver overlapped with that of CYP2E1, whose activity around the central vein area has been demonstrated to be critical for the development of APAP-induced hepatic injury. Moreover, a RIPK1 inhibitor ameliorated APAP-induced hepatotoxicity in an animal model, which was underscored by significant suppression of the release of hepatic enzymes and cytokine expression levels. RIPK1 inhibition decreased reactive oxygen species levels produced in APAP-injured hepatocytes, whereas CYP2E1 expression and the depletion rate of total glutathione were unaffected. Of note, RIPK1 inhibition also conferred resistance to oxidative stress in hepatocytes. These data collectively demonstrated a RIPK-dependent necrotic mechanism operates in the APAP-injured liver and inhibition of this pathway may be beneficial for APAP-induced fulminant hepatic failure. |
Databáze: | OpenAIRE |
Externí odkaz: |